SCHEMBL6971126

SCHEMBL6971126

COc1cc(CCO)c2ccccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.44
NPC1 O15118 1/20 0.43
LMNA P02545 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HTR4 Q13639 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PLA2G10 O15496 1/20 0.40
ACACA Q13085 1/20 0.40
CYP2D6 P10635 1/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
HTR3A P46098 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968938 0.88 POLB (0.48) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL6971124 0.84 ALOX15 (0.45) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL19422787 0.81 NPC1 (0.49) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL3968933 0.80 POLB (0.47) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL14177257 0.80 POLB (0.47) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL6629242 0.80 POLB (0.47) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL6788358 0.78 CYP2C19 (0.56) MEN1KMT2AL3MBTL1KDM4EALDH1A1
SCHEMBL12468374 0.77 CYP1A2 (0.47) ALOX15MEN1KMT2APOLBNPC1
SCHEMBL7252416 0.76 NPC1 (0.48) MEN1KMT2APOLBNPC1LMNA
SCHEMBL14300444 0.76 POLB (0.50) ALOX15MEN1KMT2APOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642255-B2 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-11-04 US disclosed
EP-1355648-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) Bristol-Myers Squibb Pharma Company (US) 2003-10-29 EP disclosed
WO-2002055491-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed